BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

Information Letter on Dacogen 50 mg, powder for concentrate for solution for infusion: Changes regarding instructions for reconstitution and shelf life

Active substance: decitabine

The company Janssen-Cilag GmbH is circulating information on measures to improve stability for reconstitution and shelf life of Dacogen.

Download DHPC / Information letter , Download_VeroeffentlichtAm_EN PDF, 555KB, File is accessible